UNSPSC 51171825: Acotiamide

This classification denotes an antiemetic agent with the molecular formula C21H30N4O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D42OWK5383. The term ACOTIAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53. ). Most nations schedule acotiamide under HS 29341000 and SITC 51579. As of Q4 2014, ACOTIAMIDE remains the US FDA Preferred Term for this commodity. Acotiamide bears US NLM identifiers UMLS ID C1879544 and NCI Concept Code C65214.

SMILES: CC(C)N(CCNC(=O)C1=CSC(=N1)NC(=O)C2=CC(=C(C=C2O)OC)OC)C(C)C.

UNSPSC 51171825 Acotiamide is a Commodity code that captures pharmaceutical testing and drug screening services procured by state and local criminal justice and healthcare agencies. Recent state and local opportunities under this code reflect two distinct service lines: offender drug testing programs operated by county corrections departments, and pharmaceutical procurement initiatives managed by state health agencies and cooperative purchasing organizations. The Collin County Community Supervision and Corrections Department RFP (2026-327) illustrates the criminal-justice testing dimension—specimen collection and drug testing services including immunoassay screening, LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, and electronic result reporting. The Texas HHS Commission RFI (HHS0017013) and the Minnesota MMCAP RFP (S1070000015802) reflect healthcare-side pharmaceutical procurement, though the latter's focus on generic multi-source drugs and OTC products sits at the periphery of the code's nominal scope rather than at its core.

Issuing bodies soliciting under this code span county-level criminal justice departments and state health and human services agencies, along with cooperative purchasing vehicles serving multiple state and local jurisdictions. Activity concentrates in Texas and Minnesota based on recent postings. The Collin County opportunity (RFP 2026-327, due July 23, 2026) budgets $600,000 annually for two-year staffing of specimen collection sites and lab testing for approximately 25,031 tests per year, with an anticipated award date of August 10, 2026; the contract requires SAMHSA, Texas DPS, or CAP lab certification and pricing on a per-test basis. The MMCAP cooperative purchasing RFP (S1070000015802, due March 26, 2026) covers generic pharmaceuticals and OTC products distributed through three authorized wholesalers across participating state and local facilities in Minnesota and Oregon, with a July 1, 2026 effective date and weighted scoring emphasizing price competitiveness at 75 percent.